Non-triple-negative breast cancer
Prevalence of Germline Mutations in Genes Engaged in DNA Damage Repair by Homologous Recombination in Patients with Triple-Negative and Hereditary Non-Triple-Negative Breast Cancers.
14
HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice.
20
The long non-coding RNA ADAMTS9-AS2 was identified as a potential prognostic biomarker in triple-negative breast cancer / O RNA longo não codificador ADAMTS9-AS2 foi identificado como um potencial biomarcador prognóstico no câncer de mama triplo negativo
17
A prognostic model for triple-negative breast cancer patients based on node status, cathepsin-D and Ki-67 index.
7
How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
11
Increased macroH2A1.1 expression correlates with poor survival of triple-negative breast cancer patients.
12
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer
13
There is no association between microRNA gene polymorphisms and risk of triple negative breast cancer in a Chinese Han population.
8
Androgen receptor expression in triple-negative breast cancer
80
Inhibition of SK4 Potassium Channels Suppresses Cell Proliferation, Migration and the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells.
17
Do hereditary syndrome related gynecologic cancers have any specific features 2015
8
Human REV3 DNA Polymerase Zeta Localizes to Mitochondria and Protects the Mitochondrial Genome.
18
Genomic testing in international guidelines
7
P02-01. Elicitation of a humoral immune response towards non-immunogenic peptides using the transcriptional transactivator of HIV-1
1
Rev. Bras. Hematol. Hemoter. vol.38 número2
4
Caracterização da expressão de microRNAS em carcinoma de mama triplo negativo
177
Depression and Anxiety Disorders among Hospitalized Women with Breast Cancer.
14
Rev. Saúde Pública vol.35 número5
7
Long non-coding RNAs as potential therapeutic targets in human breast cancer
44
PTIP associated protein 1, PA1, is an independent prognostic factor for lymphnode negative breast cancer.
11